Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4792311
rs4792311
0.030 GeneticVariation BEFREE In the stratified analyses for Ser217Leu polymorphism, there was significantly increased prostate cancer risk in Asian and Caucasian populations, and studies using sporadic and familial prostate cancer cases. 20231859

2010

dbSNP: rs486907
rs486907
0.030 GeneticVariation BEFREE Forty percent (8/20) of familial prostate cancer patients homozygous for a mutation in RNase L (R462Q) were positive for XMRV, while the virus was rarely (1/66) detected in familial prostate cancer patients heterozygous for R462Q or carrying the wild type allele. 18823818

2008

dbSNP: rs486907
rs486907
0.030 GeneticVariation BEFREE The RNASEL (encoding ribonuclease L) gene Glu265X mutation has been implicated in familial prostate cancer, and an association between the RNASEL Arg462Gln variant and sporadic and familial prostate cancer, has also been suggested. 15981205

2005

dbSNP: rs486907
rs486907
0.030 GeneticVariation BEFREE Cosegregation between the truncating mutation E265X and disease in a hereditary prostate cancer (HPC) family and association between prostate cancer risk and the common missense variant R462Q has been reported. 15534086

2004

dbSNP: rs4792311
rs4792311
0.030 GeneticVariation BEFREE Although no difference in allele frequency at Ser217Leu between patients with PCa and controls has been reported in a Western population, this polymorphism is a potential indicator of PCa risk in Japanese men and it should be examined in other ethnic groups. 12949798

2003

dbSNP: rs4792311
rs4792311
0.030 GeneticVariation BEFREE A truncating mutation was found in one hereditary prostate cancer (HPC) family, whereas two missense variants, Ser217Leu and Ala541Thr, were reported to be associated with increased PRCA risk in the general population. 11507049

2001

dbSNP: rs138213197
rs138213197
0.060 GeneticVariation BEFREE A rare recurrent missense variant in HOXB13 (rs138213197/G84E) was recently reported to be associated with hereditary prostate cancer. 25595936

2015

dbSNP: rs138213197
rs138213197
0.060 GeneticVariation BEFREE Men with the HOXB13 G84E variant had a 4.51-fold higher relative risk of PCa compared with non-carriers (95 % CI 3.28-6.20). 24026887

2014

dbSNP: rs138213197
rs138213197
0.060 GeneticVariation BEFREE A rare but recurrent missense mutation (G84E, rs138213197) in the gene homeobox B13 (HOXB13) was recently reported to be associated with hereditary prostate cancer. 22841674

2014

dbSNP: rs138213197
rs138213197
0.060 GeneticVariation BEFREE Recent genetic epidemiologic studies identified a germline mutation in the homeobox transcription factor, HOXB13 G84E, which is associated with markedly increased risk for prostate cancer, particularly early-onset hereditary prostate cancer. 24722062

2014

dbSNP: rs138213197
rs138213197
0.060 GeneticVariation BEFREE The novel HOXB13 G84E variant is associated with a significantly increased risk of hereditary prostate cancer. 22236224

2012

dbSNP: rs138213197
rs138213197
0.060 GeneticVariation BEFREE We evaluated the G84E germline mutation (rs138213197) of HOXB13 in a case-control study of familial prostate cancer at Vanderbilt University (Nashville, TN) to independently evaluate the association of the mutation with familial prostate cancer. 22714738

2012